Rockwell Medical Announces Upcoming Poster Presentation at the National Home Infusion Association’s 2022 Annual Conference
March 09 2022 - 9:00AM
Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the
“Company”), a biopharmaceutical company dedicated to transforming
the treatment of iron deficiency and anemia management and
improving outcomes for patients around the world, today announced a
poster presentation at the National Home Infusion Association’s
(NHIA) 2022 Annual Conference, to be held March 12-16 in Nashville,
Tennessee.
Details of the poster presentation are
as follows:
Title: Management of Iron Deficiency Anemia in
Home Parenteral Nutrition Patients; Challenges and Opportunities
for Improvement
Presenting Author:Timothy T. Chole, BSc Econ –
SVP, Sales & Marketing, Rockwell Medical
Co-Authors:Mark DeLegge, MD -
DeLegge MedicalMarc Hoffman, MD - Chief Medical Officer, Rockwell
MedicalMichelle C. Simpson, PharmD, BCSCP - Clinical Program
Manager, NHIAPat Anthony, MS, RD, FASPEN - Senior Director,
Organizational Growth, American Society for Parenteral and Enteral
Nutrition
Date and Time:Monday, March 14, 20221:30 pm –
3:00 pm ET
For more details on the conference, please visit
https://eventscribe.net/2022/NHIA/
A copy of the poster presentation can be accessed on the
Investors section of the Company’s website at
https://ir.rockwellmed.com once the presentation has concluded.
About Rockwell Medical Rockwell Medical is a
commercial-stage biopharmaceutical company developing and
commercializing its next-generation parenteral iron technology
platform, Ferric Pyrophosphate Citrate (FPC), which has the
potential to lead transformative treatments for iron deficiency in
multiple disease states, reduce healthcare costs and improve
patients’ lives. The Company has two FDA-approved therapies
indicated for patients undergoing hemodialysis, which are the first
two products developed from the FPC platform. Rockwell Medical is
also advancing its FPC platform by developing FPC for the treatment
of iron deficiency anemia in patients outside of dialysis, who are
receiving intravenous medications in the home infusion setting. In
addition, Rockwell Medical is one of two major suppliers of
life-saving hemodialysis concentrate products to kidney dialysis
clinics in the United States. For more information, visit
www.RockwellMed.com
About NHIA Founded in 1991, NHIA is the leading
organization providing education, information, advocacy, and
resources for the nation’s home and alternate site infusion
provider community and the manufacturers, suppliers, and service
companies that support the field.
The NHIA is committed to meeting the needs of its growing and
diverse membership—and to advocating on behalf of our members and
the home based infusion patient. Home and alternate site infusion
providers coordinate care through highly skilled professionals in a
team that will often include the infusion pharmacist, infusion
nurses, physician, and dietitian to help ensure the patient is
receiving the best care possible.
CONTACTS
Investors:Argot
Partners212.600.1902Rockwell@argotpartners.com
Media:David RosenArgot
Partners212.600.1902david.rosen@argotpartners.com
Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart
From Apr 2023 to Apr 2024